Sarepta Therapeutics Zooms Higher on Early Data Rally Promising
Sarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
Discover the smartest strategies for using a rewards credit card. Learn how to maximize benefits and save on your expenses.
27,644 articlesSarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
The euro sits around $1.16, reshaping how three Europe-focused ETFs approach currency risk. US investors must weigh e...
A new ETF focused on CTAs began trading this week, giving U.S. investors direct exposure to trend-following across mu...
United Wholesale Mortgage reports a profitable first quarter as originations slow. CEO Mat Ishbia escalates pressure ...
Toobit reports a Hacken-verified reserve surplus, with more than full coverage for customer deposits across major ass...
Major acts are trimming or canceling large legs of US tours as fans face higher prices and travel costs. Industry wat...
As the 10-year yield hovers near 4.4%, many investors chase top-yield REITs for income. The real cost chasing reit be...
In May 2026, two fresh tech IPOS are catching the eye of diligent investors. This guide breaks down why they stand ou...
A fresh look at AI's impact on entry-level accounting roles shows higher turnover and a push for revamped onboarding ...
U.S. spot Bitcoin ETFs posted seven consecutive weeks of inflows, the longest streak in months, as institutional appe...
Block slashed more than 4,000 jobs in February 2026 and reported a sharp rise in first-quarter earnings, signaling a ...
Citi lowers Lucid's price target to $14 following a disappointing Q1 2026 and the withdrawal of 2026 guidance, while ...